Clinical Trials Logo

Filter by:
NCT ID: NCT06228118 Completed - Early Pregnancy Clinical Trials

Clinical Trail of the Lay User Study and Method Comparison Study of Human Chorionic Gonadotropin (HCG) Test System

Start date: August 4, 2023
Phase:
Study type: Observational

This clinical trial consisted of lay user study and method comparison study. Method comparison study: evaluate the clinical performance by comparing the results of new device and FDA cleared device (the comparator) tested on the same sample by professionals. Lay user study: evaluate the usability of by comparing the results of new device on the same sample tested by professionals and lay user, and by lay users complete the questionnaire.

NCT ID: NCT06227195 Completed - Osteoarthritis Clinical Trials

Mechanism of IL-10 Pathway-mediated Regulatory B Cell Dysfunction in Osteoarthritis

Start date: January 1, 2019
Phase:
Study type: Observational

Our previous work has shown that Treg function is impaired in OA patients, but the cause of Treg deficiency has not been investigated. Since Breg has been shown to promote Treg differentiation and tissue repair, it is highly likely that the absence of the immunomodulatory effect of Breg in OA patients leads to impaired Treg differentiation. Based on the above data, we hypothesized that Breg plays a protective role in the course of OA by regulating T cell composition and promoting Treg differentiation through the secretion of anti-inflammatory factor IL-10

NCT ID: NCT06226922 Completed - Clinical trials for Nausea and Vomiting, Postoperative

Risk Factors for Postoperative Nausea and Vomiting in Surgical Patients Undergoing Patient-controlled Intravenous Analgesia.

Start date: July 1, 2023
Phase:
Study type: Observational

The purpose of this study is to identify the risk factors for postoperative nausea and vomiting (PONV) in surgical patients undergoing patient-controlled intravenous analgesia (PCIA).

NCT ID: NCT06226415 Completed - Clinical trials for Cerebral Small Vessel Diseases

Exploration of Stellate Ganglion Block in Patients With Cerebral Small Vessel Disease

Start date: January 20, 2024
Phase: N/A
Study type: Interventional

This is a prospective study conducted on patients with Cerebral Small Vessel Disease, dysphagia and cognitive impairment. They were divided into the comparison group and observation group evenly. All the patients were provided with routine therapy, while the patients in the observation group were given Stellate Ganglion Block. The swallowing function, cognitive function and activities of daily living of the two groups of patients before and after treatment were evaluated by Penetration-Aspiration Scale, Mini-mental state examination and modified Barthel index.

NCT ID: NCT06226350 Completed - Cervical Cancer Clinical Trials

A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma

Start date: March 4, 2021
Phase: Phase 2
Study type: Interventional

This study was an open, single-arm, enriched, multicenter Phase II study.

NCT ID: NCT06224686 Completed - Clinical trials for Deglutition Disorders

The Motor Imagery Based on Action Observation Treatment on Dysphagia in Wallenberg Syndrome

Start date: May 30, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about on dysphagia in wallenberg syndrome. The main questions it aims to answer are: - the efficacy of motor imagery based on action observation treatment in the rehabilitation of patients with dysphagia in Wallenberg syndrome. - apply functional near infrared spectroscopy to explore the mechanism of action of this therapy. Participants received conventional dysphagia treatment and motor imagery based on action observation treatment once a day for 14 days. Researchers compared the control group to see the effect and mechanism of motor imagery based on action observation treatment.

NCT ID: NCT06224608 Completed - Tuberculosis Clinical Trials

Phase I Clinical Trial to Evaluate the Safety of Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) in Healthy Adults Aged 18-65 and Patients With Pulmonary Tuberculosis

Start date: January 17, 2023
Phase: Phase 1
Study type: Interventional

The study is to enroll 60 participants aged 18-65 years old, including 30 healthy subjects and 30 tuberculosis patients. Low-dose (2.5 μg/ml), medium-dose (5 μg/ml), and high-dose (10 μg/ml) studies will be conducted separately for healthy subjects and pulmonary tuberculosis patients, with 20 participants in each dosage group. Within 28 days after the skin test of the test drug, observations were made of reactions at the skin test site, reactions at non-skin test sites, concomitant medication, and any other physical discomfort (skin test site-specific reactions were recorded separately).

NCT ID: NCT06224582 Completed - Clinical trials for Chronic Stable Angina

Yinxingmihuan Oral Solution in Treatment of Chest Pain After PCI

Start date: December 30, 2020
Phase: N/A
Study type: Interventional

A prospective, multi-center, double-blind, randomized, placebo-controlled trial is conducted to evaluate the efficacy and safety of Yinxingmihuan oral solution in the treatment of chest pain after percutaneous coronary intervention (PCI) in patients with stable angina. Patients should undergo at least 1-week standardized medical treatment phase before randomization. The primary end point is the 12-week angina frequency assessed on the basis of Seattle Angina Questionnaire (SAQ) subscales. The main secondary endpoint is the improvement of anxiety assessed by Hamilton Anxiety Scale (HAMA) to evaluate its effectiveness for chest pain caused by psychological factors.

NCT ID: NCT06224504 Completed - Clinical trials for Non-Small Cell Lung Cancer

Clinical Effectiveness of Combining Mindfulness-Based Stress Reduction With Exercise Interventione

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

This study is to assess the clinical effectiveness of combining Mindfulness-Based Stress Reduction (MBSR) with exercise intervention in improving anxiety, depression, sleep quality, and mood regulation in Chinese patients with non-small cell lung cancer (NSCLC).The control group received conventional psychological nursing care, while the intervention group received a combination of MBSR and exercise therapy. Pre- and post-treatment scores of anxiety, depression, sleep quality, and the BSRS-5 were compared.

NCT ID: NCT06221644 Completed - Clinical trials for Multiple System Atrophy

Synapse Alterations in MSA Patients

Start date: April 1, 2022
Phase:
Study type: Observational

Synaptic loss has been implicated in various neurodegenerative conditions, yet its understanding in multiple system atrophy (MSA) remains limited. The aim of this study was to examine spatial synaptic density alterations in MSA patients and evaluate the potential of [18F]SynVesT-1 PET as an imaging biomarker for MSA in both diagnosis and monitoring disease severity.